On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications like fluoxetine (Prozac), sertraline (Zoloft) and citalopram (Celexa), among others.

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of the drugs.

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not easing — the nation’s depression rates.